NYU CHES is a clinically enrolled, prospective cohort study from fetal life onward based in New York, United States of America, that aims to evaluate the influences of prenatal non-persistent chemical exposures on fetal and postnatal growth. Since March 2016, NYU CHES staff enrolled pregnant women into a biobank study from three New York University (NYU) Grossman School of Medicine affiliates: NYU Langone Hospital—Manhattan, Bellevue Hospital, and NYU Langone Hospital—Brooklyn, a diverse hospital serving a wide array of populations. Between March 22, 2016 and April 15, 2019, the study enrolled close to 2,500 pregnant women into a pregnancy biobank, of whom 2,193 women completed a questionnaire and continued into NYU CHES.
Study design
Cohort - primary caregiver and child, Biobank
Number of participants at first data collection
2,193 (mothers)
2,037 (children)
Recruitment is ongoing
Age at first data collection
≥ 18 years (mothers)
Birth (children)
Participant year of birth
Varied (mothers)
2016 - 2019 (children)
Participant sex
All
Representative sample at baseline?
Mothers in overall clinic populations.
Sample features
Country
Year of first data collection
2016
Primary Institutions
New York University (NYU)
Profile paper DOI
Funders
NIH Office of the Director
New York University
Ongoing?
Yes
Data types collected
Engagement
Keywords
Consortia and dataset groups